Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Fresenius USA

This article was originally published in The Gray Sheet

Executive Summary

Fresenius USA: Dialysis equipment manufacturer plans first quarter 1998 North American roll-out of its On-Line Clearance (OLC) dialysis dose monitor for end stage renal disease patients, the company says. The device, which gained 510(k) clearance in June, can be retrofitted to the Fresenius 2008H dialysis machine and will be included on 70-80% of all new machines sold, the firm says. Unlike competing devices, the OLC immediately provides nephrologists with treatment dose information, Fresenius maintains...



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts